UnitedHealth Group Inc. (NYSE:UNH)

The financial trajectory from 2021 to 2025 reveals a significant shift from robust economic value creation to economic value destruction. While the initial period was characterized by expanding profitability that outpaced the cost of capital, the latter years show a divergence where increasing invested capital and declining operating profits led to a negative economic profit.

Net Operating Profit After Taxes (NOPAT)

A strong upward trend is observed between 2021 and 2023, with NOPAT increasing from 18,910 million to a peak of 26,672 million. However, a sharp reversal occurred in 2024 and 2025, with figures falling to 18,940 million and 15,617 million, respectively. This represents a substantial erosion of operating profitability in the final two years of the period.

Invested Capital and Cost of Capital

Invested capital grew steadily from 139,922 million in 2021 to a peak of 198,557 million in 2024, before stabilizing at 197,568 million in 2025. Concurrently, the cost of capital remained relatively stable, fluctuating slightly around 9.3% before declining to 8.68% by 2025. The continuous expansion of the capital base increased the total capital charge required to maintain economic viability.

Economic Profit Performance

Economic profit followed a parabolic trajectory, increasing from 5,820 million in 2021 to 9,631 million in 2023. A precipitous decline is noted in 2024, where economic profit fell to 721 million, nearly eliminating the value created above the cost of capital. By 2025, the economic profit turned negative, reaching -1,526 million. This indicates that the operating returns were insufficient to cover the cost of the invested capital, resulting in a loss of economic value.

The overall analysis indicates that the decline in economic profit was driven by the simultaneous occurrence of shrinking NOPAT and an expanded capital base. Even with a reduction in the cost of capital toward the end of the period, the deterioration in operating performance was the primary driver of the transition into negative economic profit.

Net earnings attributable to UnitedHealth Group common shareholders and net operating profit after taxes (NOPAT) both demonstrate a pattern of initial growth followed by a subsequent decline over the five-year period. NOPAT exhibits a more pronounced increase initially, before experiencing a more significant decrease in later years.

NOPAT Trend

NOPAT increased from US$18,910 million in 2021 to US$26,672 million in 2023, representing a cumulative growth of approximately 41.1%. This indicates improving operational profitability during this timeframe. However, NOPAT then decreased to US$18,940 million in 2024 and further to US$15,617 million in 2025. This represents a decline of approximately 26.1% from the 2023 peak. The decrease in NOPAT in 2024 and 2025 suggests potential challenges in maintaining operational efficiency or increased costs.

Net Earnings Trend

Net earnings attributable to UnitedHealth Group common shareholders increased from US$17,285 million in 2021 to US$22,381 million in 2023, a growth of approximately 29.5%. Similar to NOPAT, net earnings then declined, reaching US$14,405 million in 2024 and US$12,056 million in 2025. This represents a decrease of approximately 46.3% from the 2023 high. The decline in net earnings mirrors the trend observed in NOPAT, suggesting a correlation between operational profitability and overall earnings.

Relationship between NOPAT and Net Earnings

While both metrics generally move in the same direction, NOPAT consistently exceeds net earnings throughout the period. This difference could be attributed to factors such as non-operating income or expenses, or differences in accounting treatment. The magnitude of the difference between NOPAT and net earnings remains relatively stable across the observed years.

The observed declines in both NOPAT and net earnings in 2024 and 2025 warrant further investigation to determine the underlying causes and potential implications for future performance.

The provision for income taxes and cash operating taxes both exhibited increasing values from 2021 to 2023, followed by declines in subsequent years. However, the magnitude and timing of these changes differed between the two items.

Provision for Income Taxes

The provision for income taxes increased from US$4,578 million in 2021 to US$5,704 million in 2022, representing a 24.6% increase. Further growth was observed in 2023, reaching US$5,968 million. A notable decrease occurred in 2024, with the provision falling to US$4,829 million, and continued to decline significantly in 2025 to US$1,890 million. This represents a substantial reduction over the two-year period from 2023 to 2025.

Cash Operating Taxes

Cash operating taxes demonstrated a similar upward trend initially, rising from US$4,823 million in 2021 to US$6,851 million in 2022, a 42.3% increase. The value continued to increase in 2023, reaching US$6,936 million. A decrease was then observed in 2024, with cash operating taxes falling to US$5,994 million. The decline continued into 2025, with cash operating taxes reported at US$4,531 million. While decreasing, the rate of decline appears less pronounced than that of the provision for income taxes.

Relationship between Provision and Cash Taxes

In 2021 and 2022, cash operating taxes were consistently higher than the provision for income taxes. This difference narrowed in 2023, and reversed in 2024 and 2025, with the provision for income taxes exceeding cash operating taxes. The divergence in 2025 is particularly significant, suggesting a substantial difference between reported tax expense and actual cash outflows for tax purposes. This could be attributable to changes in deferred tax assets or liabilities, tax credits, or other non-cash tax effects.

The observed trends suggest a potential shift in the company’s tax profile. The significant decline in both measures from 2023 to 2025 warrants further investigation to understand the underlying drivers and potential implications for future financial performance.

The invested capital of the organization demonstrates a consistent upward trend over the analyzed period, though the rate of increase fluctuates. Total reported debt & leases and shareholders’ equity attributable to UnitedHealth Group both contribute to this overall growth. A detailed examination of each component reveals specific patterns.

Total Reported Debt & Leases

Total reported debt & leases exhibits a steady increase from US$50,276 million in 2021 to US$83,004 million in 2025. The growth is not linear; a more substantial increase is observed between 2022 and 2023 (US$15,000 million) and again between 2023 and 2024 (US$14,358 million). The increase from 2024 to 2025 is comparatively modest, at US$207 million.

Shareholders’ Equity

Shareholders’ equity attributable to UnitedHealth Group also shows an increasing trend, rising from US$71,760 million in 2021 to US$94,110 million in 2025. The rate of growth is relatively consistent throughout the period, with increases ranging from approximately US$5,000 million to US$7,000 million annually. The largest increase occurs between 2022 and 2023 (US$10,984 million).

Invested Capital

Invested capital, calculated as the sum of total reported debt & leases and shareholders’ equity, increases from US$139,922 million in 2021 to US$197,568 million in 2025. The growth rate mirrors the combined trends of its components, with larger increases observed in 2023 and 2024. Notably, the increase in invested capital slows considerably between 2024 and 2025, rising by only US$754 million, suggesting a potential stabilization in capital deployment.

The consistent growth in both debt and equity suggests ongoing investment and financing activities. The slight deceleration in the growth of invested capital in the most recent year warrants further investigation to determine if this represents a strategic shift or a temporary fluctuation.

The financial performance between 2021 and 2025 is characterized by an initial period of value creation followed by a sharp reversal into value destruction. The trajectory shows a peak in economic efficiency in 2023, succeeded by a significant contraction in the ability to generate returns exceeding the cost of capital.

Economic Spread Ratio

The economic spread ratio exhibited a steady upward trend from 2021 (4.16%) to a peak of 5.27% in 2023, indicating an improving margin between the return on invested capital and the weighted average cost of capital. However, a precipitous decline occurred in 2024, with the ratio falling to 0.36%, before turning negative in 2025 at -0.77%. This transition signifies that by 2025, the returns generated were insufficient to cover the cost of the capital employed.

Economic Profit

Economic profit followed a similar pattern to the spread ratio, increasing from US$ 5,820 million in 2021 to a peak of US$ 9,631 million in 2023. A severe erosion of economic profit is observed in 2024, where the figure dropped to US$ 721 million. This downward trend culminated in a negative economic profit of US$ -1,526 million by December 31, 2025, representing a complete reversal of the value-creation trend seen in the first three years.

Invested Capital

Invested capital grew consistently from US$ 139,922 million in 2021 to a peak of US$ 198,557 million in 2024. Unlike the economic profit and spread ratio, invested capital remained relatively stable and high through 2025, ending at US$ 197,568 million. The disconnect between the continued growth of the capital base and the collapsing economic profit suggests a diminishing efficiency in how the deployed capital is generating returns.

The overall analysis indicates a critical pivot point in 2023. While the organization successfully expanded its economic spread and profit through 2023, the subsequent period reveals a failure to maintain these returns relative to the expanding capital base, ultimately resulting in negative economic value added by the end of 2025.

The financial performance over the five-year period reveals a significant divergence between top-line revenue growth and the generation of economic value. While adjusted revenues expanded consistently, economic profit and the associated margin experienced a sharp reversal following a peak in 2023.

Economic Profit Margin Trend

The economic profit margin exhibited a positive trajectory in the initial years, increasing from 2.04% in 2021 to a peak of 2.62% in 2023. This upward trend was followed by a precipitous decline to 0.18% in 2024, eventually shifting into negative territory at -0.34% by 2025.

Economic Profit Performance

Absolute economic profit grew steadily from US$ 5,820 million in 2021 to US$ 9,631 million in 2023. However, this growth was not sustained; a substantial contraction occurred in 2024, where profit fell to US$ 721 million, culminating in an economic loss of US$ 1,526 million in 2025.

Revenue Growth Dynamics

Adjusted revenues from customers demonstrated uninterrupted growth throughout the analyzed timeframe. Revenues rose from US$ 285,002 million in 2021 to US$ 443,743 million in 2025, indicating a strong and consistent expansion of the business scale.

The contrast between the steady increase in adjusted revenues and the collapse of economic profit suggests that the costs associated with the capital employed grew at a rate that eventually eclipsed the operating returns. The transition to a negative economic profit margin by 2025 indicates that the entity failed to generate returns above its cost of capital during the final period of the analysis.